Genomic Vision: Frederic Hammel

Genomic Vision, a French biotech company specializing in structural genomics and functional genome analysis, has appointed Frederic Hammel as chief operating officer. Hammel was previously CEO of Ethera, a company that produces air-quality products. Prior to that he was CEO at Platine Pharma Services (later acquired by a BioMérieux subsidiary). He has also served as CEO of TxCell, a clinical-stage developer of cell-based immunotherapies.